Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Mash”

92 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 92 results

Not applicableStudy completedNCT05630521
What this trial is testing

Testing Feasibility of Medication Adherence Problem Solving for Hypertension

Who this might be right for
HypertensionAdherence, Medication
Rush University Medical Center 40
Not applicableLooking for participantsNCT06813508
What this trial is testing

Prognostic Factors for HCC and Liver Transplantation in Patients With MASLD/MASH

Who this might be right for
Metabolic Dysfunction-Associated Steatotic Liver DiseaseHepatocellular CarcinomaMetabolic Dysfunction-Associated Steatohepatitis+1 more
IRCCS Azienda Ospedaliero-Universitaria di Bologna 1,000
Testing effectiveness (Phase 2)Looking for participantsNCT06588699
What this trial is testing

Digoxin In NASH (CODIN)

Who this might be right for
NASHNAFLDMASH - Metabolic Dysfunction-Associated Steatohepatitis+5 more
Yale University 144
Testing effectiveness (Phase 2)Looking for participantsNCT06920043
What this trial is testing

Efimosfermin Alfa in Participants With Biopsy-confirmed Cirrhosis (Compensated) Due to MASH

Who this might be right for
Metabolic Dysfunction-Associated Steatohepatitis
Boston Pharmaceuticals 42
Early research (Phase 1)Looking for participantsNCT06485245
What this trial is testing

Study to Evaluate Safety, Tolerability and Pharmacokinetics of CS060304 in Healthy and Elevated LDL-C Subjects

Who this might be right for
MASH
Cascade Pharmaceuticals, Inc 80
Post-approval studies (Phase 4)Looking for participantsNCT06523530
What this trial is testing

Effect of a GnRH Analog on Hepatic Steatosis

Who this might be right for
Metabolic Dysfunction-Associated Steatotic Liver DiseaseNonalcoholic Fatty LiverEndometriosis
Aristotle University Of Thessaloniki 62
Testing effectiveness (Phase 2)Looking for participantsNCT07145151
What this trial is testing

UBT251 in Participants With Metabolic Dysfunction-Associated Steatohepatitis (MASH)

Who this might be right for
Metabolic Dysfunction-associated Steatohepatitis (MASH)
The United Bio-Technology (Hengqin) Co., Ltd. 156
Post-approval studies (Phase 4)Looking for participantsNCT07249788
What this trial is testing

Resmiterom Efficacy & Safety in Patients With MASH

Who this might be right for
MASH - Metabolic Dysfunction-Associated Steatohepatitis
Nabiqasim Industries (Pvt) Ltd 165
Not applicableStudy completedNCT06688149
What this trial is testing

NASH Patient's Itinerary: Comparison of Strategies for Screening, Referring and Management of Diabetic Patients

Who this might be right for
Non-alcoholic Fatty Liver Disease (NAFLD)
Fundación Pública Andaluza para la gestión de la Investigación en Sevilla 536
Not applicableActive Not RecruitingNCT07185334
What this trial is testing

Single-Stage Prepectoral Placement of Textured Implants Using a Polyester Mesh Endoprostheses With Fluoropolymer Coating in Patients With Breast Cancer

Who this might be right for
Breast CancerBreast ReconstructionCoated Materials+2 more
Saint Petersburg State University, Russia 100
Testing effectiveness (Phase 2)Study completedNCT06342947
What this trial is testing

ALG-055009 in Non-cirrhotic Adults With MASH (HERALD)

Who this might be right for
NASHMASHMetabolic Dysfunction-Associated Steatohepatitis+1 more
Aligos Therapeutics 102
Not applicableNot Yet RecruitingNCT07332611
What this trial is testing

Long Term Prediction of MASH-related HCC Risk by Proteomics

Who this might be right for
MASH-related HCC
University Hospital, Bordeaux 30
Not applicableLooking for participantsNCT06676813
What this trial is testing

Effect of Alternate Day Fasting Over Standard Medical Management Alone to Reverse Non-alcoholic Steatohepatitis.

Who this might be right for
Non Alcoholic Steatohepatitis
Institute of Liver and Biliary Sciences, India 72
Not applicableNot Yet RecruitingNCT06493253
What this trial is testing

Digital Pathology and AI for Liver Outcomes in MASLD (DPAILO-2)

Who this might be right for
Metabolic Dysfunction-associated Steatotic Liver Disease
PharmaNest, Inc 1,700
Early research (Phase 1)Active Not RecruitingNCT05395481
What this trial is testing

A Single-Ascending and Repeated Dose Study of LY3849891 in Participants With Metabolic Dysfunction-Associated Steatotic Liver Disease (MASLD)

Who this might be right for
Metabolic Dysfunction-Associated Steatohepatitis (MASH)Metabolic Dysfunction-associated Steatotic Liver Disease (MASLD)
Eli Lilly and Company 176
Not applicableLooking for participantsNCT06592820
What this trial is testing

Endoscopic Ultrasound Shear Wave Elastography Study

Who this might be right for
MASLDMASHFibrosis, Liver+1 more
Olympus Corporation of the Americas 300
Testing effectiveness (Phase 2)Study completedNCT04929483
What this trial is testing

Study Evaluating the Safety, Efficacy and Tolerability of BIO89-100 in Subjects With Biopsy-confirmed Nonalcoholic Steatohepatitis (NASH)

Who this might be right for
NASH - Nonalcoholic Steatohepatitis
89bio, Inc. 222
Large-scale testing (Phase 3)Looking for participantsNCT07221227
What this trial is testing

A Pivotal Clinical Study to Investigate Efimosfermin Alfa in Participants With Biopsy-confirmed F2- or F3-stage MASH

Who this might be right for
Non-alcoholic Fatty Liver Disease
GlaxoSmithKline 1,200
Testing effectiveness (Phase 2)Study completedNCT04906421
What this trial is testing

Study of TVB-2640 in Subjects With Nonalcoholic Steatohepatitis (NASH)

Who this might be right for
Metabolic Dysfunction-assocated Steatohepatitis/ Nonalcoholic Fatty Liver Disease
Sagimet Biosciences Inc. 168
Testing effectiveness (Phase 2)Not Yet RecruitingNCT07276204
What this trial is testing

Betaine vs. Placebo for Serologically Diagnosed Metabolic Dysfunction-associated Steatohepatitis (MASH)

Who this might be right for
MASH - Metabolic Dysfunction-Associated Steatohepatitis
Southern California Institute for Research and Education 70
Load More Results